Abstract

BackgroundCancer patients can experience a number of reproductive complications as a result of cancer treatment and may benefit from reproductive preventative health strategies. A Reproductive Survivorship Patient Reported Outcome Measure (RS-PROM) is not currently available but could assist patients address reproductive concerns.PurposeTo develop and test the acceptability, feasibility and appropriateness of a RS-PROM tool to be used to assess reproductive needs of cancer survivors aged 18–45 years.MethodsWe reviewed the outcomes of a recently published audit of reproductive care provided in our cancer survivorship clinic to identify gaps in current service provided and used this along with available validated reproductive measures, to develop this pilot RS-PROM. Survivors aged 18–45 years either attending the SCH survivorship clinic over a 1-year period or participants on the Australasian Oncofertility Registry (AOFR) who had agreed to be contacted for future research studies were asked to complete the RS-PROM and a questionnaire on the acceptability, feasibility and appropriateness of content included.ResultsOne-hundred and fifty patients participated (61.3% females). Median age at cancer diagnosis was 24.5 years (range: 2–45 years). Eighty percent of participants reported the length of the RS-PROM was “just right”, 92% agreed they would not mind completing the RS-PROM and 92.7% were willing to answer all questions, with 97% agreeing that the RS-PROM would be an important tool in addressing difficult sexual/reproductive topics concerning with healthcare professionals.ConclusionThe large majority of survivors participating in our pilot study found the RS-PROM to be an acceptable, feasible and useful tool to assist discussions of their sexual and reproductive health concerns and experiences with their clinical team.

Highlights

  • Improvements in treatment of cancer patients have led to significant improvements in survival rates [1,2]

  • We reviewed the outcomes of a recently published audit of reproductive care provided in our cancer survivorship clinic to identify gaps in current service provided and used this along with available validated reproductive measures, to develop this pilot Reproductive Survivorship Patient Reported Outcome Measure (RS-Patient Reported Outcome Measures (PROMs))

  • Eighty percent of participants reported the length of the RS-PROM was “just right”, 92% agreed they would not mind completing the RS-PROM

Read more

Summary

Introduction

Improvements in treatment of cancer patients have led to significant improvements in survival rates [1,2]. One of the most devastating effects of cancer treatment include the late-effects consequences on a patient’s fertility, ability to have children in the survivorship period, their increased risks of medical complications (cardiovascular and bone health) and heightened psychological distress and anxiety (affecting relationships with a partner, sexuality and quality of life) [3,4]. A variety of concerns around their sexual and reproductive health in the survivorship period are reported in survivors [5,6] and their un-met need for opportunity and to address these [5]. Risks will vary according to cancer type and stage, age at diagnosis, treatment received as well as a patient’s previous reproductive history and previous endocrine issues [7]. To develop and test the acceptability, feasibility and appropriateness of a RS-PROM tool to be used to assess reproductive needs of cancer survivors aged 18–45 years

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call